NextNRG, Inc. Reports Third Quarter 2026 Financial Results
NextNRG, Inc. announced its financial results for the third quarter ended September 30, 2026, reporting revenue of $26.7 million and a narrowed net loss.
Stocks · News reference
U.S. stocks mixed: Nasdaq +1.3%, S&P +0.85%, Dow -0.12%. Tech led gains; health care lagged. Boyd Group fell 12% after weak results.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
NextNRG, Inc. announced its financial results for the third quarter ended September 30, 2026, reporting revenue of $26.7 million and a narrowed net loss.
NextNRG Inc. reported a quarterly loss of $6.88 per share, slightly beating consensus estimates of $7 loss, with revenues of $26.72 million missing expectations by 4.9%. The stock has declined 99.2% year-to-date versus the S&P 500's 10.5% gain. The company holds a Zacks Rank #3 (Hold) rating with mixed estimate revisions, expected to perform in line with the market.
NextNRG announced Q3 2026 financial results with revenue rising 16.9% to $26.7 million and net loss narrowing 45.2%. However, the company faces significant headwinds including suspension from Nasdaq (now trading OTC Pink), reduced fuel gallons delivered, and gross profit decline despite revenue growth. Nine-month results showed 28.4% revenue growth but 57.4% net loss improvement, driven primarily by reduced stock-based compensation and interest expenses.
NextNRG, Inc. announced it will host a conference call on November 17, 2026, at 9:15 a.m. ET to discuss its third quarter 2026 financial results and provide a corporate update. The company is an AI-driven energy innovation firm that deploys smart controllers in microgrids and operates EV charging and mobile fueling services.
Basel Medical Group Ltd has completed a registered direct offering of 6,000,000 units, raising approximately US$7.98 million in gross proceeds.
Filed: 2026-11-13 AccNo: 0001493152-26-051712 Size: 204 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 9.01: Financial Statements and Exhibits